「et」の検索結果
142件：16～20件目を表示
-
研究開発の取り組み | 千寿製薬株式会社
Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-...
http://www.senju.co.jp/english/rd/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
onStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） SJP-0170Gla...
http://www.senju.co.jp/english/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...
http://www.senju.co.jp/english/news/ -
Quality Policies | About Senju | SENJU Pharmaceutical
We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...
http://www.senju.co.jp/english/about/quality.html -
Overseas Activities | SENJU Pharmaceutical
a, we established a local subsidiary, Jiangsu Senju Pharmaceutical Co., Ltd., to strengthen our marketing system and steadily lay the groundwork for globalization. Overseas bases BEIJING OFFICEBeijing...
http://www.senju.co.jp/english/global/